Related Experiment Videos
[Kinin-modifying therapy of patients with myocardial infarction]
Insights
Serum alpha 1-proteinase inhibitor levels in acute myocardial infarction patients correlate with disease severity. Rapid determination of these levels may guide targeted inhibitor therapy for better outcomes.
Area of Science:
- Cardiology
- Biochemistry
Background:
- Myocardial infarction (MI) is a leading cause of mortality worldwide.
- Early identification of MI severity is crucial for effective treatment.
- Alpha 1-proteinase inhibitor (A1PI) plays a role in inflammatory processes.
Purpose of the Study:
- To investigate the relationship between serum A1PI levels and clinical characteristics in acute MI patients.
- To determine if A1PI levels can predict MI severity and clinical course.
Main Methods:
- Patients with acute MI were classified into four groups based on clinical features and serum A1PI levels within 1-3 days of onset.
- Serum A1PI levels were measured using a rapid method.
Main Results:
- Four distinct patient groups were identified.
- The most severe MI cases were observed in patients belonging to Groups 1 and 4.
- A significant correlation was found between serum A1PI ratios and the clinical course of acute MI.
Conclusions:
- Serum A1PI levels are closely associated with the clinical course and severity of acute myocardial infarction.
- Rapid determination of A1PI titers can aid in identifying high-risk patients.
- This may facilitate goal-oriented therapeutic strategies, including inhibitor therapy.
Abstract:
According to clinical characteristics and serum levels of alpha 1-proteinase inhibitor in the acute period (1-3 days), four groups of patients with myocardial infarction were identified. The most severe myocardial infarction was observed in patients from Groups 1 and 4. It was found that the serum alpha 1-proteinase inhibitor ratios in acute myocardial infarction were closely related to its clinical course. In the authors' opinion, determination of alpha 1-proteinase inhibitor titers by the rapid method will allow the goal-oriented therapeutical measures, including inhibitor therapy to be used.